iAnthus Capital Holdings, Inc. ITHUF IAN reported its financial results for the first quarter ended March 31, 2022.
Q1 2022 Financial Highlights
-
Revenue of $42.8 million, a sequential decrease of 10% from Q4 2021 and a decrease of 17% from the same period in the prior year.
-
Gross profit of $22.5 million, relatively flat when compared to Q4 2021 and a decrease of 24% from the same period in the prior year.
-
Gross margin of 52.6%, reflecting a sequential increase of 560bps from Q4 2021 and a decrease of 480bps from the same period in the prior year.
-
Net loss of $10.1 million, or a loss of $0.06 per share, compared to a loss of $26.9 million or a loss of $0.16 per share in Q4 2021, and compared to a loss of $19.5 million, or a loss of $0.11 per share, in the same period in the prior year.
-
Adjusted EBITDA of $3.4 million, a sequential decrease from $8.2 million in Q4 2021 and decrease from $13.0 million from the same period in the prior year.
Management Changes
On May 4, 2022, the company announced the resignation of co-founder and interim CEO, Randy Maslow from his executive positions with the company, including all positions with the company's subsidiaries and its affiliates, and from the company's board of directors and committees, effective as of May 6, 2022. Maslow will continue to serve the company in a consulting role for a period of six months following the Resignation Date.
On May 6, 2022, the company appointed Robert Galvin as interim CEO and member of the board, effective as of May 6, 2022.
Opening of Atlantic City, New Jersey Dispensary
On May 5, 2022, the company opened its first dispensary in the state of New Jersey. The dispensary, which operates under the MPX NJ brand, is located in Atlantic City, New Jersey.
Related News
iAnthus Names Robert Galvin Interim CEO & Board Member, Provides Business Update
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.